Precipitation of acute angle closure glaucoma following withdrawal of donepezil hydrochloride

Authors

  • Uvaraj Thresika Department of Ophthalmology, Amala Institute of Medical Sciences, Amala Nagar, Thrissur, Kerala, India
  • Sebastian Nayana Department of Ophthalmology, Amala Institute of Medical Sciences, Amala Nagar, Thrissur, Kerala, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20150570

Keywords:

Acute angle closure glaucoma, Donepezil hydrochloride, Alzheimer’s disease, Iridotomy, Drug withdrawal glaucoma

Abstract

Drug induced bilateral acute angle closure glaucoma (AACG) is well known entity reported but accidental withdrawal of a drug precipitating an attack of AACG is rare. Abrupt termination of donepezil, an FDA approved acetylcholinesterase inhibitor to treat mild to moderate Alzheimer’s disease, is often attributed to occurrence of side effects. In this case, incidence of bilateral AACG following discontinuation of donepezil hydrochloride in a 76-year-old female patient with Alzheimer’s disease is presented.

References

Ritch R, Lowe RF. Angle closure glaucoma: Mechanisms and epidemiology. In: Ritch R, Shields MB, Krupin T, editors. The glaucoma’s. 2nd ed. St Louis: CV Mosby Year Book Inc.; 1996; 801–819.

Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007;18:129–33.

Geldmacher DS. Donepezil (Aricept) for treatment of Alzheimer’s disease and other dementing conditions. Expert Rev Neurother. 2004;4:5–16.

Shigeta M, Homma A. Donepezil for Alzheimer’s disease: pharmacodynamics, pharmacokinetic, and clinical profiles. CNS Drug Rev. 2001;7:353–68.

Doody RS. Clinical profile of donepezil in the treatment of Alzheimer’s disease. Gerontology. 1999;45(Suppl 1):23–32.

Umegaki H, Itoh A, Suzuki Y, Nabeshima T. Discontinuation of donepezil for the treatment of Alzheimer’s disease in geriatric practice. Int Psychogeriatr IPA. 2008;20:800–6.

Bidzan L, Bidzan M. Withdrawal syndrome after donepezil cessation in a patient with dementia. Neurol Sci. 2012;33:1459–61.

Wilkinson DG. The pharmacology of donepezil: a new treatment of Alzheimer’s disease. Expert Opin Pharmacother. 1999;1:121–35.

Román GC, Rogers SJ. Donepezil: a clinical review of current and emerging indications. Expert Opin Pharmacother. 2004;5:161–80.

Estermann S, Daepp G-C, Cattapan-Ludewig K, Berkhoff M, Frueh BE, Goldblum D. Effect of Oral Donepezil on Intraocular Pressure in Normotensive Alzheimer Patients. J Ocul Pharmacol Ther. 2006;22:62–7.

Enzenauer RW, Bowers PJ. Angle-closure glaucoma after discontinuing donepezil hydrochloride (Aricept). J Gerontol A Biol Sci Med Sci. 2005;60:1083.

Downloads

Published

2017-02-09